Stereotaxis, Inc.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
STXS$1.09+3.8%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets
| (in thousands, except share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $14,616 | $13,421 |
| Accounts receivable, net of allowance of $630 and $541 at 2026 and 2025, respectively | 5,303 | 5,847 |
| Insurance receivable | 4,316 | 4,316 |
| Inventories, net | 10,495 | 9,567 |
| Prepaid expenses and other current assets | 1,297 | 698 |
| Total current assets | 36,027 | 33,849 |
| Property and equipment, net | 2,956 | 3,019 |
| Goodwill | 3,764 | 3,764 |
| Intangible assets, net | 6,193 | 6,429 |
| Operating lease right-of-use assets | 4,760 | 4,912 |
| Prepaid and other non-current assets | 330 | 278 |
| Total assets | $54,030 | $52,251 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $4,823 | $4,768 |
| Accrued liabilities | 1,478 | 2,065 |
| Accrued legal liabilities | 4,316 | 4,316 |
| Deferred revenue | 6,541 | 5,675 |
| Current contingent consideration | 5,266 | 4,894 |
| Current portion of operating lease liabilities | 662 | 642 |
| Total current liabilities | 23,086 | 22,360 |
| Long-term deferred revenue | 523 | 555 |
| Long-term contingent consideration | 5,108 | 4,724 |
| Operating lease liabilities | 4,618 | 4,794 |
| Other liabilities | 1,097 | 1,097 |
| Total liabilities | 34,432 | 33,530 |
| Series A - Convertible preferred stock: | ||
| Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 21,008 shares outstanding at 2026 and 2025 | 5,240 | 5,240 |
| Stockholders’ equity: | ||
| Common stock, par value $0.001; 300,000,000 shares authorized, 97,491,248 and 95,339,628 shares issued at 2026 and 2025, respectively | 97 | 95 |
| Additional paid in capital | 603,696 | 596,960 |
| Treasury stock, 4,015 shares at 2026 and 2025 | (206) | (206) |
| Accumulated deficit | (589,229) | (583,368) |
| Total stockholders’ equity | 14,358 | 13,481 |
| Total liabilities and stockholders’ equity | $54,030 | $52,251 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.